These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 34516531)

  • 1. Cuba's National Regulatory Authority & COVID-19: Olga Lidia Jacobo-Casanueva MS Director, Center for State Control of Medicines and Medical Devices (CECMED).
    Aguilar-Guerra TL; Fajardo-Díaz EM; Gorry C
    MEDICC Rev; 2021; 23(3-4):9-14. PubMed ID: 34516531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccines and Public Trust: Containing COVID-19 in Cuba.
    Gorry C
    MEDICC Rev; 2022 Jan; 24(1):9-13. PubMed ID: 35157633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal Antibodies vs COVID-19: Eduardo Ojito-Magaz MS General Director, Molecular Immunology Center.
    Aguilar TL; Gorry C
    MEDICC Rev; 2021 Apr; 23(2):12. PubMed ID: 33974610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SOBERANA, Cuba's COVID-19 Vaccine Candidates: Dagmar García-Rivera PhD.
    Gorry C
    MEDICC Rev; 2020 Oct; 22(4):10-15. PubMed ID: 33295312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cuban COVID-19 Vaccines for Children: Rinaldo Puga MD MS Principal Investigator, Pediatric Clinical Trials for Soberana 02 and Soberana Plus.
    Reed G
    MEDICC Rev; 2022 Jan; 24(1):14-18. PubMed ID: 35157634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Science at the Service of Public Health: Rafael Pérez Cristiá MD PhD Center for State Control of Medicines and Medical Devices.
    Gorry C
    MEDICC Rev; 2018 Jan; 20(1):8. PubMed ID: 34229415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Researchers at Cuba's National Medical Genetics Center: Pioneering Studies on COVID-19.
    Reed GA
    MEDICC Rev; 2021 Jan; 23(1):12-17. PubMed ID: 33780417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 Requires Innovation, Regulation and Rigor: Amaylid Arteaga-García MD MS Director, National Clinical Trials Coordinating Center (CENCEC).
    Aguilar TL; Gorry C
    MEDICC Rev; 2021 Apr; 23(2):9. PubMed ID: 33974607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cuba.
    United States. Department of State. Bureau of Public Affairs
    Backgr Notes Ser; 1985 Aug; ():1-8. PubMed ID: 12178121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "Cuba's Medical Team in the European Epicenter of COVID-19: Carlos R. Pérez-Díaz MD MS PhD Director, Joaquín Albarrán Provincial Clinical-Surgical Hospital, Havana Henry Reeve Medical Contingent Leader, Lombardy, Italy".
    Coutin G; Gorry C
    MEDICC Rev; 2021 Jan; 23(1):18-20. PubMed ID: 33780418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In Haiti, Cubans Among First Responders, Again: Luis Orlando Oliveros-Serrano MD Coordinator, Cuban Medical Team in Haiti.
    Gorry C
    MEDICC Rev; 2022 Jan; 24(1):19-20. PubMed ID: 34653117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bringing Cuban Biotech Research to Bear on COVID-19:All Hands and Minds on Deck.
    Castellanos-Serra L
    MEDICC Rev; 2020 Apr; 22(2):31-37. PubMed ID: 32478705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human immunodeficiency virus in Cuba: the public health response of a Third World country.
    Santana S; Faas L; Wald K
    Int J Health Serv; 1991; 21(3):511-37. PubMed ID: 1917211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of the two doses conjugated protein-based SOBERANA-02 COVID-19 vaccine and of a heterologous three-dose combination with SOBERANA-Plus: a double-blind, randomised, placebo-controlled phase 3 clinical trial.
    Toledo-Romaní ME; García-Carmenate M; Valenzuela-Silva C; Baldoquín-Rodríguez W; Martínez-Pérez M; Rodríguez-González M; Paredes-Moreno B; Mendoza-Hernández I; González-Mujica Romero R; Samón-Tabio O; Velazco-Villares P; Bacallao-Castillo JP; Licea-Martín E; Rodríguez-Ortega M; Herrera-Marrero N; Caballero-González E; Egües-Torres L; Duartes-González R; García-Blanco S; Pérez-Cabrera S; Huete-Ferreira S; Idalmis-Cisnero K; Fonte-Galindo O; Meliá-Pérez D; Rojas-Remedios I; Doroud D; Gouya MM; Biglari A; Fernández-Castillo S; Climent-Ruiz Y; Valdes-Balbín Y; García-Rivera D; Van der Stuyft P; Verez-Bencomo V;
    Lancet Reg Health Am; 2023 Feb; 18():100423. PubMed ID: 36618081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CUBA'S COVID-19 STRATEGY: UPDATED EPIDEMIC CONTROL AND RECOVERY MEASURES.
    MEDICC Rev; 2020 Jul; 22(3):5. PubMed ID: 32812892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stemming COVID-19 in Cuba: Strengths, Strategies, Challenges Francisco Durán MD. National Director of Epidemiology, Ministry of Public Health, Cuba.
    Reed G
    MEDICC Rev; 2020 Apr; 22(2):47-52. PubMed ID: 32478709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cuba's Pedro Kourí Tropical Medicine Institute:Battling COVID-19 One Study, One Test, One Patient at a Time.
    Coutin G; Bacallao-Gallestey J; Castellanos-Serra L
    MEDICC Rev; 2020 Apr; 22(2):40-44. PubMed ID: 32478707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Empowering Cuban Women: Marta Núñez MS PhD, Sociologist & Consulting Professor, University of Havana.
    Gorry C
    MEDICC Rev; 2018 Jul; 20(3):6-9. PubMed ID: 31242155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19 Case Detection: Cuba's Active Screening Approach.
    Gorry C
    MEDICC Rev; 2020 Apr; 22(2):58-63. PubMed ID: 32478711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cuba's COVID-19 Strategy: Main Actions through April 23, 2020.
    MEDICC Rev; 2020 Apr; 22(2):50-52. PubMed ID: 33295309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.